Results 181 to 190 of about 134,100 (245)

Role of remdesivir for the treatment of COVID‐19 in patients with hematologic malignancy—A narrative review and expert opinion

European Journal of Clinical Investigation, EarlyView.
Created in BioRender. Ghezzi, S. (2025) https://BioRender.com/q1lticg. Abstract Background COVID‐19 remains a potentially severe condition for immunocompromised individuals, such as patients with hematologic malignancy. These patients are at increased risk of progressing to severe–critical or prolonged COVID‐19.
Malgorzata Mikulska, Matteo Bassetti, Alessandro Busca, Valeria Cento, Maddalena Giannella, Michele Bartoletti   +5 more
wiley   +1 more source

Burkitt Lymphoma Presenting With Acute Kidney Injury and Facial Nerve Palsy: A Case Report With Literature Review. [PDF]

Clin Case Rep
Odeh G, Yassin F, Abuomar J, Abdallah A.
europepmc   +1 more source

Metagenomic analysis of DNA viruses from posttransplant lymphoproliferative disorders [PDF]

, 2019
Chen, Chun-Cheng, Dharnidharka, Vikas R, Goss, Charles W, Gu, Hongjie, O\u27Gorman, Harry, Parameswaran, Priyanka, Ruzinova, Marianna B, Storch, Gregory A, Wylie, Kristine   +8 more
core   +2 more sources

Enitociclib (VIP152), venetoclax and prednisone in relapsed or refractory aggressive non‐Hodgkin lymphoma

British Journal of Haematology, EarlyView.
Max J. Gordon, Rahul Lakhotia, Stefania Pittaluga, Svetlana D. Pack, Anna Marie Juanitez, Ahmed Hamdy, Amy J. Johnson, Melanie M. Frigault, Raquel Izumi, Mark Raffeld, Mark Roschewski, Wyndham H. Wilson, Christopher Melani   +12 more
wiley   +1 more source

Toll‐Like Receptor Polymorphisms Influence Graft‐Versus‐Host Disease and Infection Risk After Single‐Unit Cord Blood Transplantation for Adults

European Journal of Haematology, EarlyView.
ABSTRACT Background Toll‐like receptors (TLRs) play a critical role in innate immunity by recognizing pathogen‐associated and damage‐associated molecular patterns. Genetic polymorphisms in TLR genes can modulate immune responses and have been implicated in the outcomes of allogeneic hematopoietic cell transplantation (HCT).
Takaaki Konuma, Megumi Hamatani‐Asakura, Seiko Kato, Shohei Andoh, Hirona Ichimura, Junichi Kuroda, Kaori Kondo, Kazuaki Yokoyama, Maki Monna‐Oiwa, Yasuhito Nannya, Satoshi Takahashi   +10 more
wiley   +1 more source

Development and internal validation of a lymphoma-specific nomogram for predicting venous thromboembolism: a retrospective cohort of 790 patients. [PDF]

BMC Cancer
Pan L, Lin W, Qiu Y, Chen J, Li N, Liu T.   +5 more
europepmc   +1 more source

Core Needle Biopsies in Patients With Lymphoproliferative Malignancies: An Observational Single‐Center Cohort Study

European Journal of Haematology, EarlyView.
ABSTRACT In the diagnostic evaluation of suspected lymphoma, both core needle biopsy (CNB) and surgical excisional biopsy (SEB) are routinely employed for tissue sampling. While SEB remains the gold standard, CNB is a less invasive and more cost‐effective alternative. However, concerns persist regarding its diagnostic yield.
Blas Holger Mogensen, Torsten Holm Nielsen, Mette Ølgod Pedersen, Lise Mette Rahbek Gjerdrum, Tarec Christoffer El‐Galaly, Lars Møller Pedersen   +5 more
wiley   +1 more source

Global incidence of childhood cancer by subtype in 2022: a population-based registry study. [PDF]

EClinicalMedicine
Wang M, Bi Y, Fan Y, Fu X, Jin Y.
europepmc   +1 more source

Cardiovascular Challenges in Chronic Lymphocytic Leukemia (CLL) Patients Undergoing Bruton Tyrosine Kinase (BTK) Inhibitor Therapy

European Journal of Haematology, EarlyView.
ABSTRACT Background/Objectives Bruton tyrosine kinase inhibitors (BTKis) have revolutionized treatment for chronic lymphocytic leukemia (CLL), but cardiovascular (CV) toxicities pose significant challenges. Second‐generation BTKis offer improved target specificity, yet CV risks persist.
Stefano Oliva, Stefano Molica
wiley   +1 more source

Epidemiological Profile of Non-Hodgkin's Lymphomas Seen at Kinshasa University Clinics From 2012 to 2022. [PDF]

Cancer Med
Julia MN, David A, Serge P, Fabrice B, Germain KK, Didier BN, Olive K, Bienvenu LM, Jean-Marie KM.   +8 more
europepmc   +1 more source